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A protein's life inside a cell is usually terminated by the 
action of proteases that hydrolyse the polypeptide to small 
peptides or free amino acids. Many proteolytic enzymes 
are specific for only a few protein substrates, or they medi- 
ate highly specialized functions. Promiscuous proteases 
with broad specificities, however, are generally seques- 
tered and reside within specialized organelles known as 
lysosomes or vacuoles. Such compartmentalization is vi- 
tal, as constitutively active, free proteases with broad 
specificities would be disastrous for proteinaceous cellular 
companions. 
The ubiquitin/proteasome system stands out from the 
nonlysosomal proteolytic systems because it has the ca- 
pacity to degrade almost any protein but generally remains 
a harmless neighbor of intracellular proteins. A number 
of exciting discoveries in various fields have finally brought 
this system into the limelight (reviewed by Ciechanover, 
1994; Hochstrasser, 1995). Ubiquitin/proteasome-mediated 
degradation was recently found to be instrumental in the 
regulation of a wealth of diverse cellular functions, such 
as DNA repair, cell cycle progression, signal transduction, 
transcription, and antigen presentation. A major clue as 
to how this degradation system operates came from the 
recently reported crystal structure of the proteasome 
(L0we et al., 1995). Several implications of these findings 
will be addressed below. 
Protein Targeting 
The lifespan of intracellular proteins can differ by several 
orders of magnitude. Structural proteins or proteins that 
are constitutively required are usually long-lived. In con- 
trast, key regulatory proteins are often rapidly degraded. 
Their degradation, which can be precisely timed and regu- 
lated, offers the possibility of an instant switch from one 
functional cellular program to another. Recent examples 
of regulatory proteins that are turned over by the ubiquitin/ 
proteasome pathway are the transcription factors MAT~2 
and GCN4 from yeast, the c-jun gene product, a segment 
of the precursor of the p50 subunit of NF-KB, IKB, the 
tumor suppressor protein p53, the Mos kinase, cyclins, 
inhibitors of cyclin-dependent kinases, and the ~ subunit 
of a trimeric G protein (reviewed by Jentsch, 1992; Cie- 
chanover, 1994; Hochstrasser, 1995). Moreover, the ubi- 
quitin/proteasome system also detects and eliminates ab- 
normal proteins such as misfolded proteins or proteins 
that would otherwise be part of a larger complex but fail 
to find their partners. 
The challenge for this pathway is to identify and destroy 
from a large pool of proteins only those whose degradation 
is desired. Proteins are assumed to bear specific degrada- 
tion signals analogous to those that target proteins to cer- 
tain organelles or compartments. However, proteolytic sig- 
nals are expected to be more complex in their organization 
and sequence diversity than targeting signals because 
they should indicate not only whether the protein has to 
be degraded, but also at what rate and when. To decode 
each of these putative signals, nature has evolved a spe- 
cialized recognition and targeting apparatus, the ubiqui- 
tin-conjugation system (reviewed by Jentsch, 1992). This 
system seems to operate functionally and spatially de- 
tached from the protease, the proteasome, in both the 
cytosol and the nucleus of eukaryotic cells. Recognized 
substrates are earmarked by the covalent attachment of 
ubiquitin, a small and highly stable protein. Ubiquitin 
linked via its carboxyl terminus to internal lysine residues 
of the substrates seems to act, at least in part, as a sort- 
ing signal, targeting conjugates to the proteasome. In 
most cases several ubiquitin molecules are added to the 
substrate as a multiubiquitin chain in which ubiquitin 
molecules are arranged like beads on a string. Multiubiq- 
uitinated proteins are apparently preferred by the pro- 
teasome. 
Conjugation of ubiquitin to substrate proteins requires 
a reaction cascade (Jentsch, 1992; Scheffner et al., 1995). 
Initially, ubiquitin-activating (El) enzyme hydrolyses ATP 
and forms a thioester bond between itself and ubiquitin. 
Ubiquitin is then passed on to ubiquitin-conjugating (E2) 
enzymes and often subsequently to ubiquitin ligases (E3). 
Conjugation of ubiquitin to substrate proteins is thought 
to be catalyzed by either E2 alone or by a combination of 
E2 with E3. Interestingly, both E2 and E3 proteins exist 
as large families, and members of each family seem to 
differ in their properties and intracellular localization. In- 
deed, mutations in individual genes for different yeast E2 
enzymes revealed that these enzymes are involved in dis- 
tinct processes such as DNA repair, cell cycle progression, 
peroxisome biogenesis, heat shock resistance, and cad- 
mium tolerance (Jentsch, 1992; Seufert et al., 1995). At 
least some E2 enzymes can form heterodimers with each 
other, and it is assumed that diverse combinations of E2s 
with different E3 proteins is likely to define the large reper- 
toire of substrate specificities. 
Proteasome: Form Follows Function 
Proteins tagged with multiubiquitin chains are degraded 
by the proteasome, yielding small peptides in a reaction 
that requires ATP. Proteasomes are abundant (up to 1% 
of cellular protein) multisubunit particles (reviewed by Pe- 
ters, 1994). In eukaryotes they reside in the cytosol and 
the nucleus, but are apparently absent from other cellular 
compartments. Proteasomes can be isolated as particles 
with sedimentation coefficients of 20S and 26S; the 20S 
particle represents the proteolytically active core of the 
larger particle. It is unclear whether free 20S particles exist 
in a cell and display biological activity or whether they are 
simply a consequence of the fractionation procedure. 20S 
proteasomes with virtually indistinguishable basic struc- 
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tural features can be purified from all eukaryotes, archae- 
bacteria, and (as shown recently) even some eubacteria 
(Tamura et al., 1995), indicating that they are common to 
many forms of life. The 20S core particle is barrel shaped, 
with four stacked rings each comprising seven polypep- 
tides. The prototype is represented by the proteasome 
from the archaebacterium Thermoplasma, which is as, 
sembled from two different but related proteins called c( 
and 13. The rings at both ends of the proteasome cylinder 
are formed by ~ subunits and the two central rings by 
13 subunits, resulting in a stoichiometry of (~7137137(~. 20S 
proteasomes from eukaryotes have shown a more com- 
plex organization as families of (~- and 13-related proteins 
have evolved. In yeast seven genes for (~-Iike and seven 
genes for 13-like subunits have been identified, and all 14 
gene products are apparently assembled into the same 
20S particle (Chen and Hochstrasser, 1995). 
The recently reported crystal structure of the 20S protea- 
some from the archaebacterium Thermoplasma is excep- 
tionally informative (LSwe et al,, 1995). The barrel-shaped 
particle forms a central channel that widens at three posi- 
tions, forming three chambers: two smaller chambers, one 
at each end of the channel, and a third large central cham- 
ber built by the two 13 rings. The catalytically active sites 
are associated with the 13 subunits and are buried deep 
inside the proteasome in the central chamber. The (~ rings 
on both ends of the particle form narrow gates with a diam- 
eter of 13/~, that would presumably only allow the passage 
of unfolded polypeptide chains into the proteasome. This 
architectu re elegantly explains why the protease, although 
promiscuous in its specificity, does not degrade cellular 
proteins constitutively: proteins must first be unfolded and 
threaded through the bottleneck of the proteasome before 
they are accessible to the catalytic sites inside the barrel. 
After proteolysis, it is unlikely that peptides could pass 
through the tightly packed outer walls of the cylinder but 
probably leave the proteasome either at the site of entry, 
as in a blender, or via the opposite gate, as in a mill. As 
the structure of the 20S proteasome has a perfect two-fold 
symmetry, both ways of peptide release seem possible. 
.p~roteasomes from Thermoplasma seem to lack cleav- 
age specificity in general. Hydrolysis by the proteasome 
requires a threonine residue at the amino terminus of the 
I~ subunit; the hydroxyl group forms the active nucleophile 
(SeemL~ller et al., 1995). Interestingly, this threonine resi- 
due of eukaryotic 13 subunits is the target of a Streptomyces 
antibiotic called lactacystin that covalently binds to this 
residue, thereby irreversibly inactivating eukaryotic pro- 
teasomes (Fenteany et al., 1995). The distance of the cata- 
lytic Sites of the first 13 ring to those of the second 13 ring 
corresponds roughly to the length of an extended polypep- 
tide chain of seven to eight amino acids. It has been sug- 
gested that this "molecular ruler" may specify fragment 
length since proteasomes seem to generate fragments of 
about that size (L6we et al., 1995). 
The localization of the active sites of the I~ subunits in- 
side the central cavity of the proteasome prevents uncon- 
trolled proteolysis. But how is unrestrained degradation 
avoided when the 13 subunits are not yet assembled into 
the barrel? Similar to lysosomal proteases, proteasomal 
13 subunits are made as inactive precursors. The lysosomal 
enzymes are processed and thus activated once they 
reach their target compartment, whereas the processing 
of the 13 precursors is linked to proteasome assembly 
(Zwickl et al., 1994). Assembly probably begins with the 
formation of heptameric a rings. These rings subsequently 
seem to stimulate the autocatalytic removal of the pro se- 
quence from 13 precursors and guide the assembly of pro- 
cessed, mature I~ subunits into ordered heptameric I~ rings 
stacked onto the (1 rings. Two preassembled halves (a7137) 
apparently then rapidly associate to form fully active 20S 
proteasomes. 
Feeding the Proteasome 
Purified 20S proteasomes can efficiently degrade small 
peptides, but they are inactive on intact, folded proteins 
(Peters, 1994). Ubiquitin-conjugate recognition and pro- 
tein unfolding are likely to be mediated by at least some of 
the - 16 proteins that, together with the 20S proteasome, 
form the 26S complex. These proteins, in the size range 
of 35-110 kDa, assemble to separate complexes called 
19S caps (reviewed by Peters, 1994; Hochstrasser, 1995). 
In the presence of ATP, 19S caps can bind to both identical 
ends of the 20S proteasome in vitro, generating particles 
that have caps either on only one end or on both ends of 
the cylinder. Several genes for known or suspected 19S 
cap proteins have recently been cloned, but their cellular 
functions remain to be rigorously established. However, 
the following sequence of events that precedes the degra- 
dation of proteins inside the 20S proteasome can be hy- 
pothesized (Figure 1). 
The initial events in this pathway probably involve the 
recognition and anchoring of ubiquitin chains of conju- 
gates to subunit 5, a 19S cap protein that binds ubiquitin 
chains (Deveraux et al., 1994). We propose that substrates 
may remain virtually "chained" to this or similar receptors 
until enzymes of the cap have successfully unfolded seg- 
ments of the protein and initiated the translocation of the 
polypeptide chain through the bottleneck of the 20S pro- 
teasome. Such a mechanism would enable the system to 
unfold selectively only those substrates that are tethered 
to the cap by flexible ubiquitin chains, leaving free, diffus- 
ible proteins intact. We suggest that the remarkably stable 
structure of ubiquitin may have evolved to withstand the 
unfolding forces of the enzymes of the cap, thus pre- 
venting the degradation of ubiquitin chains together with 
substrates. Protein unfolding is probably catalyzed by a 
set of similarly sized 19S cap proteins that belong to a 
novel family of ATPases (Dubiel et al., 1992). Relatives 
of these enzymes are the Escherichia coil proteins CIpA 
and ClpX, which both seem to exhibit intrinsic ATP- 
dependent chaperone activities (Wawrzynow et al., 1995) 
and are supposed to assemble on top of the cylinder- 
shaped CIp protease and provide specificity to the enzyme 
(Kessel et al., 1995). Analogous activities could be ex- 
pected for the ATPases of the 19S cap. These ATPases, 
possibly arranged as a ring, may contact the 20S barrel 
directly, as binding of the cap to the barrel is known to be 
ATP dependent. At a certain stage, perhaps triggered by 
the unfolded state of the substrate, the attached multiubi- 
quitin chain must be removed to allow the complete trans- 
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Figure 1. Hypothetical Ubiquitin/Proteasome 
Pathway 
Initially, aconjugate of a substrate with multiple 
ubiquitin molecules (red) is formed and binds 
to the 26S proteasome (the 20S proteolytically 
active core is shown as a green cylinder; 19S 
caps on both ends of the 20S cylinder are sche- 
matically shown as gray cylinders). Subse- 
quently, the polypeptide chain is unfolded and 
translocated into the 20S cylinder, where it is 
degraded. The ubiquitin chain is removed 
and disassembled. Peptides may be released 
through both openings of the proteasome. 
location of the substrate into the proteasome. Yeast DOA4, 
a deubiquitination enzyme, is a likely candidate for this 
activity: mutants in this enzyme accumulate multiubiquiti- 
nated substrates that appear partially degraded (Papa and 
Hochstrasser, 1993). The multiubiquitin chains freed from 
the substrate but probably still bound to the receptor are 
presumably rapidly cleaved to single ubiquitin moieties by 
an enzyme called isopeptidase T (Hadari etal., 1992). Its 
activity is probably required to clear multiubiquitin recep- 
tors from chains and to recycle ubiquitin. Finally, the un- 
folded polypeptide is completely translocated into the cen- 
tral chamber of the proteasome, where it is degraded. 
Proteasomes may not only mediate the complete degra- 
dation of proteins, but also the processing of precursors 
into mature, active proteins. Recent evidence indicates 
that the p50 subunit of transcription factor NF-KB is gener- 
ated by a ubiquitin/proteasome-dependent reaction that 
involves the degradation of the carboxy-terminal portion 
of its precursor (Palombella etal., 1994). Incomplete deg- 
radation could be achieved if polypeptide chains fail to be 
fully translocated into the 20S barrel. This model predicts 
translocation arrest and protein release mechanisms. An 
alternative and simpler model, in which p50 is cleaved off 
prior to degradation of the carboxy-terminal portion of the 
precursor, seems more attractive. Whatever the mecha- 
nism, generation of p50 and degradation of the carboxy- 
terminal portion of the precursor are tightly coupled, sug- 
gesting that all the activities required for this reaction are 
probably associated with the 26S proteasome. 
More than Destruction; Antigen Processing 
Antigen processing for presentation by major histocom- 
patibility complex (MHC) class I molecules is now widely 
believed to involve the ubiquitin/proteasome system (re- 
viewed by Ciechanover, 1994). Recent studies indicate 
that proteasomes may be specifically altered tosatisfy the 
requirements of this special task. 
Human proteasomes probably contain only three dis- 
tinct active [3 subunits; the remaining four 13 subunits of 
the proteasome seem to lack the active sites (Seem011er 
etal. ,  1995). Intriguingly, all three active subunits are 
down-regulated by the antiviral agent interferon-7 (IFN~,), 
whereas three other active [3 subunits are reciprocally up- 
regulated. Two of these up-regulated subunits, LMP2 and 
LMP7, are encoded bythe MHC locus. The functional con- 
sequence of the IFNT-induced replacement of apparently 
all active subunits of the 20S proteasome remains un- 
clear. Conflicting evidence has been presented as to how 
the cleavage site specificity might be affected. Relevant 
changes in the characteristics of the generated peptides 
are indeed expected, as cells from mice deficient for either 
LMP2 or LMP7 show significant defects in the presentation 
of certain antigens (Fehling etal., 1994; Van Kaer etal., 
1994). A reasonable possibility is that peptides generated 
by remodeled proteasomes may be tailored--in respect 
to their size and sequence--to the specificities of peptide 
transporters, MHC molecules, or both. 
Proteasomes eem to undergo additional changes upon 
IFN~, induction: two related proteins, PA28~ and PA2813, 
are coordinately induced and assemble into an oligomeric 
ring-shaped particle called the PA28 activator (Ahn etal., 
1995). PA28 can bind to both ends of the 20S proteasome 
and can accelerate the rate of hydrolysis of peptides. Since 
19S caps and PA28 activators compete for the same sites 
at the 20S barrel, asymmetric proteasomes, furnished with 
a 19S cap on one end and an activator on the other, may 
exist. How PA28 activates proteasomes is not known, but 
it may directly influence catalysis by inducing favorable 
conformational changes in the 13 subunits or may perhaps 
accelerate proteolysis by clearing the proteasome of pro- 
teolytic debris. 
Conclusions 
The structure of the cell's protein degradation machine 
and its mode of action resemble that of the mills, grinders, 
and slicers found in kitchens. These comparatively simple 
machines can be manipulated in three ways: by exchang- 
ing blades with different shapes; by setting the speed of 
the rotating blades; and by adjusting the force that pushes 
the substrate through the machine. Proteasomes may be 
controlled by similar parameters: exchanging 13 subunits 
may affect the cleavage site specificity; by raising the ac- 
tivity of [3 subunits, e.g., through protein modification, 
smaller fragments may be generated; and increasing the 
activity of the ATPases may accelerate protein breakdown 
but may yield larger rather than smaller peptides. Since 
many proteasomal genes have been cloned, these ideas 
can now be tested. 
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